Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis

Serum microRNA Biomarkers for Drug-Induced Liver Injury

(2012) P J Starkey Lewis et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet

(2012) Volodymyr P. Tryndyak et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis

(2012) Natalia Elfimova et al.   Frontiers in Physiology

Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection

(2011) Verena Bihrer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Drug Safety Sciences and the Bottleneck in Drug Development

(2011) P B Watkins   CLINICAL PHARMACOLOGY & THERAPEUTICS

The mechanistic basis for the induction of hepatic steatosis by xenobiotics

(2011) David E Amacher   Expert Opinion on Drug Metabolism & Toxicology

Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection

(2011) O. Waidmann et al.   JOURNAL OF VIRAL HEPATITIS

Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease

(2011) Silvia Cermelli et al.   PLoS One

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

(2011) J. D. Arroyo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases

(2010) Y. Zhang et al.   CLINICAL CHEMISTRY

Animal Models of Non-Alcoholic Steatohepatitis: Of Mice and Man

(2010) J.M. Schattenberg et al.   DIGESTIVE DISEASES

Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155 and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice

(2010) Igor P Pogribny et al.   LABORATORY INVESTIGATION

Animal models of nonalcoholic fatty liver disease

(2010) Lionel Hebbard et al.   Nature Reviews Gastroenterology & Hepatology

New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)

(2009) Rafeeq Ali et al.   ANNALS OF MEDICINE

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

(2009) C Coulouarn et al.   ONCOGENE

Circulating microRNAs, potential biomarkers for drug-induced liver injury

(2009) K. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recent advances in nonalcholic fatty liver disease

(2008) Victoria Greenfield et al.   CURRENT OPINION IN GASTROENTEROLOGY

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

(2008) Onpan Cheung et al.   HEPATOLOGY